Davide Masi

Medical Doctor

Specialized in Endocrinology, Andrology, and Metabolic Diseases.

Clinical researcher in Endocrinology: main fields of expertise include obesity, nutrition, type 2 diabetes, thyroid and adrenal endocrinology.

Currently, PhD student in Endocrinological Sciences at "Sapienza University", Rome, IT. Skilled Researcher enthusiastic about supporting advancements in Endocrinology.

• SIO school 2022 - Training Course – Italian Society of Obesity
• Alfiere del lavoro Prize – Presidenza della Repubblica Italiana
• Sorgente Group - Annual scholarship 2019
• Isituto di studi superiori "Giuseppe Toniolo" - Annual scholarship. 2012
• IIT - Center for Biomolecular Nanotechnologies -Fellowship 2010

- "European Society of Endocrinology" (ESE);

- "Italian Society of Obesity" (SIO);

- "Italian Society of Endocrinology" (SIE);

- “European Society of Obesity” (EASO);

- "Association Française d'Etude et de Recherche sur l'Obésité" (AFERO)

MSSG 2023 Oral communication

• Masi, D. , et al. Exploring the Untapped Potential: Unraveling the Role of the Upper Small Intestine Microbiome in Metabolic Diseases

SIE 2023 Oral communication

• Masi, D. , et al. Logic Learning Machine identifica i predittori del raggiungimento degli obiettivi lipidici nei pazienti con diabete di Tipo 2: conclusioni del gruppo di studio AMD

ECE 2023 Oral communication

• Masi, D. , et al. "The Role of Logic Learning Machine in Predicting Lipid Goal Attainment Among Type 2 Diabetes Outpatients : Results from the AMD Annals Study Group" Endocrine Abstracts. Vol. 82

ECE 2022 Accepted posters

• Masi, D. , et al. "MRI intensity and pituitary volume predict adult-onset growth hormone deficiency in patients with obesity and overweight: a new potential tool guiding subsequent diagnostic testing." Endocrine Abstracts. Vol. 81. Bioscientifica, 2022.
• Masi, D. , et al. "Chondrosarcoma of the cavernous sinus treated with postoperative proton radiation therapy: case report and endocrinological follow up after 36 months." Endocrine Abstracts. Vol. 81. Bioscientifica, 2022.
• Masi, D. , Risi, R., Tozzi, R., Gangitano, E., Curreli, M., Watanabe, M., ... & Lubrano, C. (2022, May). IGF1-zSDS in patients suffering from obesity with or without metabolic syndrome: a cross-sectional study in 2032 subject. In Endocrine Abstracts (Vol. 81). Bioscientifica.
• Tozzi, R., Masi, D ., Cipriani, F., Elena, S. M., Contini, S., Watanabe, M., ... & Mariani, S. (2022, May). The crosstalk between adiposity and bone: a potential role for SIRT1 and sclerostin. In Endocrine Abstracts (Vol. 81). Bioscientifica.
• Tozzi, R., Basciani, S., Rossetti, R., Balena, A., Masi, D. , Risi, R., ... & Lubrabno, C. (2022, May). Reduction in Oxytocin levels predict body weight loss in patients with obesity after a very low carbohydrate ketogenic diet (VLCKD). In Endocrine Abstracts(Vol. 81). Bioscientifica.

- Ermenegildo Zegna Founder's Scholarship 2022

- Short-Term Fellowship Grants | ESE 2022

- Bioscientifica Trust Grant 2022

- Bando di Ateneo Sapienza University 2022, Tissue-based immunofluorescence antibody testing in the evaluation of autoimmune obesity in patients with low leptin levels: a pilot study, Protocol Number: AR1221816773FFC6

- Bando di Ateneo Sapienza University 2022, A translational pilot study evaluating the acute effects of different macronutrient compositions on circulating Sirtuin-1, adiposity indices, incretin responses and brown adipose tissue activation: a possible role for ketone bodies, Protocol Number: RM122181681F2246

- Bando di Ateneo Sapienza University 2021, Effects of different eating and sleeping pattern, dietary regimens , physical activity levels and bariatric surgery on syst, mic and tissue inflammatory response, sars-cov2 antibody titer and body composition in obesity : a cross over controlled randomized study, Protocol Number: RM12117A61EAEC9A

- Bando di Ateneo Sapienza University 2020 Sirtuina1 e Sclerostina: il nesso fisiopatologico tra obesità e osteoporosi. Studio osservazionale, cross-sectional. Protocol Number: RP120172B9E980D7

Citations in ResearchGate: 365, Publication in ResearchGate: 25, H index Scopus: 8, Publications in Scopus: 19

Most relevant publications:

• Masi, D ., et al. (2023). Nourishing the Gut: The Impact of Diet on Host-Gut Microbiota Interaction. Current Opinion in Clinical Nutrition and Metabolic Care (accepted, in Press)
• Risi, R., [...], Masi, D ., et al. (2023). Postbariatric Surgery Hypoglycemia: nutritional, pharmacological and surgical perspectives. Diabetes/Metabolism Research and Reviews
• Masi, D ., et al. (2023). Upper small intestine microbiome in obesity and related metabolic disorders: A new field of investigation. Metabolism, 155712.
• Masi, D ., et al. (2023). Obésité et risque cardiovasculaire: le rôle de la chirurgie bariatrique dans la modulation du microbiote intestinal. ScienceDirect (online version)
• Masi, D ., et al. (2023). Uncovering Predictors of Lipid Goal Attainment in Type 2 Diabetes Outpatients Using Logic Learning Machine: Insights from the AMD Annals and AMD Artificial Intelligence Study Group." Journal of Clinical Medicine 12.12 (2023): 4095.
• Masi, D ., et al. (2023) Obesity-Associated Hepatic Steatosis, Somatotropic Axis Impairment, and Ferritin Levels Are Strong Predictors of COVID-19 Severity. Viruses 15.2 (2023): 488.
• Masi, D ., Tozzi, R., Watanabe, M., (2023). Genome Editing and Obesity, book chapter in Advances in Experimental Medicine and Biology, 1396, pp. 179–190
• Masi, D ., Tozzi, R., Watanabe, M., (2022). Obesità: genetica e dintorni." L'Endocrinologo (2022): 1-7
• Tozzi, R., Cipriani, F., Masi, D. , Basciani, S., Watanabe, M., Lubrano, C., ... & Mariani, S. (2022). Ketone Bodies and SIRT1, Synergic Epigenetic Regulators for Metabolic Health: A Narrative Review. Nutrients, 14(15), 3145.
• Masi, D ., et al., (2022). The Influence of Ketone Bodies on Circadian Processes Regarding Appetite, Sleep and Hormone Release: A Systematic Review of the Literature. Nutrients, 14(7), 1410.
• Gangitano, E., Barbaro, G., Susi, M., Rossetti, R., Spoltore, M. E., Masi, D ., ... & Lubrano, C. (2022). Growth Hormone Secretory Capacity Is Associated with Cardiac Morphology and Function in Overweight and Obese Patients: A Controlled, Cross-Sectional Study. Cells, 11(15), 2420.
• Masi, D ., et al., (2022). Application of a Machine Learning Technology in the Definition of Metabolically Healthy and Unhealthy Status: A Retrospective Study of 2567 Subjects Suffering from Obesity with or without Metabolic Syndrome. Nutrients, 14(2), 373
• Tozzi, R., Masi, D ., Cipriani, F., Contini, S., Gangitano, E., Spoltore, M. E., ... & Mariani, S. (2022). Circulating SIRT1 and Sclerostin Correlates with Bone Status in Young Women with Different Degrees of Adiposity. Nutrients, 14(5), 983.
• Risi, R., Rossini, G., Tozzi, R., Pieralice, S., Monte, L., Masi, D. , ... & Watanabe, M. (2022). Gender Difference in the Safety and Efficacy of Bariatric Procedures: a Systematic Review and Meta-analysis. Surgery for Obesity and Related Diseases.
• Watanabe, M., Balena, A., Tuccinardi, D., Tozzi, R., Risi, R., Masi, D ., ... & Gnessi, L. (2022). Central obesity, smoking habit, and hypertension are associated with lower antibody titres in response to COVID‐19 mRNA vaccine. Diabetes/metabolism research and reviews, 38(1), e3465.
• Watanabe, M., Balena, A., Masi, D ., Tozzi, R., Risi, R., Caputi, A., ... & Gnessi, L. (2022). Rapid Weight Loss, Central Obesity Improvement and Blood Glucose Reduction Are Associated with a Stronger Adaptive Immune Response Following COVID-19 mRNA Vaccine. Vaccines, 10(1), 79.
• Masi D , et al., Letter to the Editor: "Our Response to COVID-19 as Endocrinologists and Diabetologists". J Clin Endocrinol Metab. 2020 Jul 1;105(7):dgaa229.
• Lubrano, C., Masi, D ., Risi, R., Balena, A., Watanabe, M., Mariani, S., & Gnessi, L. (2020). Is Growth Hormone Insufficiency the Missing Link Between Obesity, Male Gender, Age, and COVID‐19 Severity?. Obesity, 28(11), 2038-2039.
• Watanabe, M., Risi, R., Masi, D. , Caputi, A., Balena, A., Rossini, G., ... & Lubrano, C. (2020). Current evidence to propose different food supplements for weight loss: A comprehensive review. Nutrients, 12(9), 2873.
• Lubrano, C., Risi, R., Masi, D. , Gnessi, L., & Colao, A. (2020). Is obesity the missing link between COVID-19 severity and air pollution?. Environmental Pollution, 266, 115327.
• Risi, R., Masieri, S., Poggiogalle, E., Watanabe, M., Caputi, A., Masi. D, ... & Lubrano, C. (2020). Nickel Sensitivity Is Associated with GH-IGF1 Axis Impairment and Pituitary Abnormalities on MRI in Overweight and Obese Subjects. International Journal of Molecular Sciences, 21(24), 9733.
• Masi, D. , Risi, R., Basciani, S., Tuccinardi, D., Mariani, S., Lubrano, C., ... & Watanabe, M. (2021). Very low-Calorie Ketogenic diets to Treat patients with obesity and chronic kidney disease. Journal of Renal Nutrition, 31(4), 340-341.

I authorise the processing of the personal data contained in my curriculum vitae in accordance with art. 13 of Legislative Decree 196/2003 and art. 13 of EU Regulation 2016/679 on the protection of individuals with regard to the processing of personal data.

Rome, December 2023